lapatinib has been researched along with Microsatellite Instability in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arcella, P; Arena, S; Barbosa, F; Bardelli, A; Bertotti, A; Cancelliere, C; Cassingena, A; Corti, G; Di Nicolantonio, F; Durinikova, E; Garnett, MJ; Isella, C; Lazzari, L; Linnebacher, M; Medico, E; Montone, M; Novara, L; Picco, G; Sartore-Bianchi, A; Siena, S; Trusolino, L; Zanella, ER | 1 |
1 other study(ies) available for lapatinib and Microsatellite Instability
| Article | Year |
|---|---|
Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Cohort Studies; Colon; Colorectal Neoplasms; Drug Resistance, Neoplasm; Exome Sequencing; Female; Gene Dosage; Humans; Lapatinib; Male; Mice; Microsatellite Instability; Middle Aged; Precision Medicine; Primary Cell Culture; Rectum; RNA-Seq; Trastuzumab; Treatment Outcome; Werner Syndrome Helicase; Xenograft Model Antitumor Assays | 2019 |